摘要
目的分析血清同型半胱氨酸检测对急性脑梗死患者的临床价值。方法将我院2014年3月~2015年8月收治的50例急性脑梗死患者作为观察组,另选取同期在我院体检的50例健康者作为对照组,对两组血清同型半胱氨酸进行检测,并分析和对比检测结果。结果经对比分析,脑梗死患者血清同型半胱氨酸水平为（27.5±8.5）μmol/L,异常检出率为96.00%;对照组血清同型半胱氨酸水平为（13.1±2.1）μmol/L,异常检出率为6.00%;组间比较差异均具有统计学意义（P〈0.05）。结论血清同型半胱氨酸与急性脑梗死的发生和发展具有密切联系,对该指标进行检测有利于急性脑梗死的预防及治疗。
Objective To analyze the clinical value of serum homocysteine in patients with acute cerebral infarction. Methods 50 cases of acute cerebral infarction treated in our hospital from March 2014 to August 2015 were selected as the observation group,and 50 cases of healthy persons were selected as control group. The serum homocysteine was detected in two groups,and the results were analyzed and compared. Results The serum homocysteine level in cerebral infarction patients was（27.5±8.5）μmol/L, the abnormal detection rate was 96%, and the control group（13.1±2.1） μmol/L, the abnormal detection rate was 6%, the comparison between the two groups was statistically significant（P〈0.05）. Conclusion Serum homocysteine has a close relationship with the occurrence and development of acute cerebral infarction,which is beneficial to the prevention and treatment of acute cerebral infarction.
出处
《中国卫生标准管理》
2015年第30期154-155,共2页
China Health Standard Management
关键词
血清同型半胱氨酸
急性脑梗死
检测
临床价值
Serum homocysteine
Acute cerebral infarction
Detection
Clinical value
